Pluri Inc. Stock Analysis & AI Score
Pluri Inc. (PLUR) has an ST Score of 46.2 (C+), driven by its Forecast (A) and held back by its Momentum (D). PLUR last traded at $1.05.
Composite rating from 8 factors. Tap a factor to see the metrics behind its grade.
Company Information
| Employees | — |
| CEO | — |
| Sector | Healthcare |
| Industry | Biotechnology |
| IPO Date | — |
| Website | — |
| Country | — |
| Exchange | NASDAQ |
SEC Filings
Annual Report (10-K)
| Filing Date | Accepted | Link |
|---|---|---|
| Loading… | ||
Quarterly Report (10-Q)
| Filing Date | Accepted | Link |
|---|---|---|
| Loading… | ||
ST Score
Pluri Inc. (PLUR) has an ST Score of 46.2 (C+), driven by its Forecast (A) and held back by its Momentum (D). PLUR last traded at $1.05.
- Strongest
- ForecastA
- Weakest
- MomentumD
All factor grades
- ForecastA
- GrowthB+
- ProfitabilityB
- ValuationC
- Financial StrengthC-
- MomentumD
- Piotroski2/9
Contact
PLUR stock: frequently asked questions
What is PLUR's ST Score?
Pluri Inc. (PLUR) has an ST Score of 46.2 (C+), on our 0–100 scale where higher is stronger. The ST Score combines eight factor grades — valuation, profitability, financial strength, momentum, growth, forecast, sentiment and Piotroski — into a single A+ to F rating.
Is PLUR a buy, hold, or sell?
Our ST Score grades it C+ (46.2/100). The ST Score is a data-driven signal, not a recommendation.
What are PLUR's factor grades?
Valuation C, Profitability B, Financial Strength C-, Momentum D, Growth B+, Forecast A.
What is PLUR's valuation grade?
Pluri Inc. (PLUR) earns a valuation grade of C, measured against Biotechnology peers. The valuation factor looks at multiples such as P/E, P/S, P/B, EV/EBITDA and free cash flow yield.
What is PLUR's growth grade?
Pluri Inc. (PLUR) earns a growth grade of B+, measured against Biotechnology peers. The growth factor looks at revenue, earnings and cash flow growth over recent quarters and years.
What is PLUR's profitability grade?
Pluri Inc. (PLUR) earns a profitability grade of B, measured against Biotechnology peers. The profitability factor looks at margins and returns such as gross margin, net margin, ROE and ROIC.
What is PLUR's financial strength grade?
Pluri Inc. (PLUR) earns a financial strength grade of C-, measured against Biotechnology peers. The financial strength factor looks at debt levels, liquidity and coverage ratios.
What is the analyst price target for PLUR?
The average analyst price target for Pluri Inc. (PLUR) is $12.00, which is +1042.9% versus the recent price of $1.05.
What is PLUR's Piotroski score?
Pluri Inc. (PLUR) has a Piotroski F-Score of 2 out of 9. The Piotroski score checks nine accounting signals covering profitability, leverage and operating efficiency; scores of 8–9 are considered strong and 0–2 weak.